The Microbiology Stewardship Assistant embeds laboratory-published organism trends, resistance patterns, and antibiogram summaries directly into the EMR. It integrates LIS-originated data via HL7v2 result events and SMART on FHIR panels, providing clinicians with current susceptibility insights without requiring access to separate lab dashboards or stewardship databases.
This assistant improves situational awareness by surfacing local resistance patterns and susceptibility distributions, by unit, facility, or time period, helping clinicians align empiric therapy choices with current data while maintaining LIS ownership of interpretive content.
Benefits
- Strengthens antimicrobial stewardship: Empowers clinicians to choose evidence-based empiric therapy aligned with local resistance trends.
- Improves care efficiency: Reduces toggling between EMR and LIS systems during decision-making.
- Enhances situational awareness: Surfaces organism and susceptibility trends by site or care area.
- Supports stewardship reporting: Provides visibility into antibiogram evolution over time for infection control initiatives.
Capabilities
- SMART on FHIR visualization: Displays antibiogram and organism distribution data using FHIR
ObservationandDiagnosticReportresources. - HL7v2 event integration: Consumes LIS-published result events to update EMR-side dashboards in near real time.
- Context-aware filters: Allows clinicians to drill down by unit, facility, specimen type, or organism family.
- Stewardship overlays: Displays contextual therapy guidance and policy notes alongside susceptibility summaries.
- Governed data flow: Preserves LIS authority for interpretive text while enabling EMR-level visualization and trending.
Great for
- Clinical Informatics and EMR Analysts: Embed stewardship dashboards that blend LIS-published antibiogram data with EMR context using HL7v2 and FHIR interoperability.
- Infectious Disease and Antimicrobial Stewardship Teams: Review resistance trends and organism distributions directly at the point of care to guide empiric therapy and track stewardship performance.
- Clinical Decision Support Architects: Integrate susceptibility-based nudges and contextual guidance into result review and order-entry workflows using SMART on FHIR and stewardship overlays.
- Infection Prevention and Quality Teams: Monitor multi-site antibiogram patterns for resistance surveillance and compliance reporting.
Interops Team integrates LIS-published microbiology and antibiogram data using HL7v2
OBX events and SMART on FHIR visualization, enabling EMR-embedded stewardship views that preserve LIS ownership and enhance point-of-care decision support.